Comparative in vitro antimicrobial activity of tigecycline against clinical isolates of vancomycin-resistant enterococcus

Indian Journal of Medical Microbiology

Volumn 27, Issue 4, 2009, Pages 373-374

  Yemisen, M ^a   Demirel, A ^a   Mete, B ^a   Kaygusuz, A ^b   Mert, A ^a   Tabak, F ^a   Ozturk, R ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CLAVULANIC ACID; IMIPENEM; LEVOFLOXACIN; LINEZOLID; PENICILLIN G; PIPERACILLIN; TAZOBACTAM; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; DISK DIFFUSION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 70349323187     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.55455     Document Type: Letter

References (4)

1. Sum PE, Petersen P. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett 1999;9:1459-1462
2. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 7th ed. Approved Standard M07-A7. Wayne, PA, USA: CLSI; 2006.
3. Garrison MW, Nuemiller JJ. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin resistant enterococci. Int J Antimicrob Agents 2007;29:191-196
4. Cercenado E, Cercenado S, Gómez JA, Bouza E. In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin resistant enterococci and staphylococci with diminished susceptibility to glycopeptides. J Antimicrob Chemother 2003;52:138-139